THE ACTION OF HUMAN CHORIONIC GONADOTROPHIN PREPARATIONS ON THE ADRENALS AND TESTICLES OF HYPOPHYSECTOMIZED IMMATURE RATS

1950 ◽  
Vol 5 (1) ◽  
pp. 43-53 ◽  
Author(s):  
E. DICZFALUSY ◽  
HJ. HOLMGREN ◽  
A. WESTMAN
Keyword(s):  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Immature Rats

STIMULATION BY β2-ADRENERGIC RECEPTORS OF THE PRODUCTION OF CYCLIC AMP AND PROGESTERONE IN RAT OVARIAN TISSUE

1980 ◽  
Vol 87 (1) ◽  
pp. 123-129 ◽  
Author(s):  
ALBERT RATNER ◽  
G. K. WEISS ◽  
CAROLYN R. SANBORN
Keyword(s):  
Cyclic Amp ◽  
Adrenergic Receptors ◽  
Ovarian Tissue ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Adrenergic Stimulation ◽  
Immature Rats ◽  
Luteal Tissue ◽  
Pregnant Mare Serum Gonadotrophin ◽  
Stimulation Of

Ovarian tissue from immature rats treated with pregnant mare serum gonadotrophin (PMSG) or PMSG and human chorionic gonadotrophin was incubated in Medium 199. Stimulation of the formation of cyclic AMP in follicular and luteal tissue by terbutaline (10−5 mol/l), a selective β2-agonist, was blocked by butoxamine (10−5 mol/l), a selective β2-antagonist, whereas practolol (10−5 mol/l), a selective β1-antagonist, was ineffective. Propranolol (10−5 mol/l), a non-selective β-antagonist, butoxamine nor practolol affected the increase in cyclic AMP promoted by the addition of 1 μg LH. Stimulation of the production of progesterone in both follicular and luteal tissue by terbutaline was blocked by butoxamine, but not by practolol. These findings indicated that β-adrenergic stimulation of ovarian cyclic AMP and progesterone is mediated by β2-adrenergic receptors.

FOLLICLE STIMULATING HORMONE-LIKE ACTIVITY IN HUMAN CHORIONIC GONADOTROPHIN PREPARATIONS

1969 ◽  
Vol 60 (1) ◽  
pp. 137-156 ◽  
Author(s):  
C. Robyn ◽  
P. Petrusz ◽  
E. Diczfalusy
Keyword(s):  
Follicle Stimulating Hormone ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Female Rats ◽  
Immature Female ◽  
Ovarian Weight ◽  
Wide Range ◽  
Immature Rats ◽  
Stimulation Of ◽  
Stimulating Hormone

ABSTRACT The follicle stimulating hormone (FSH)-like activity of human chorionic gonadotrophin (HCG) preparations was assayed by the method based on the ovarian weight augmentation in intact immature rats. The potencies ranged from 4.8 to 7.4 IU equivalents of FSH per mg. The FSH-like potency of the Second International Standard Preparation of HCG was 8.5 IU per vial. However, when in intact immature rats the ovarian weight response to HCG preparations was compared at a wide range of doses (40 to 51 200 IU) to that obtained with a human menopausal gonadotrophin (HMG) preparation (0.5 to 128 IU of FSH) in the presence of 40 IU of HCG, significant differences were found. The assays conducted in hypophysectomised immature female rats were invalid, because of lack of parallelism. Antisera were prepared by immunising rabbits with HCG and human hypophysial gonadotrophin (HHG) preparations and the antigonadotrophin profiles (HCG-, FSH- and FSH-like neutralising potencies) of these antisera were established by the use of statistically valid bioassay procedures. The anti-HCG and anti-HHG sera neutralised the FSH activity of HMG preparations as well as the FSH-like activity of HCG preparations. However, 3 to 175 times more antiserum was required to neutralise the equivalent of 1.0 IU of FSH-like activity present in HCG than expected on the basis of the anti-FSH potency of the antisera. On the other hand, there was a high degree of correlation between the neutralising potencies of the antisera when tested against the FSH-like activity and the HCG activity of various HCG preparations. When the FSH-like activity of an HCG preparation was quantitatively neutralised with an anti-HCG serum, some 30 per cent of the HCG activity remained unneutralised, as evidenced by repeated bioassays. Although at least 2000 IU of this »FSH-free« HCG was administered to groups of intact as well as hypophysectomised immature female rats, this high dose of HCG did not induce an increase in ovarian weight beyond that elicited by 40 IU of untreated HCG. Histological examination of the ovaries indicated lack of follicle stimulation in the hypophysectomised, but not in the intact immature animals. There was an excessive stimulation of the interstitial cells in both types of animals. The data indicate that the FSH-like activity of HCG preparations is neither due to a contamination by FSH of pituitary origin, nor is it an evenly distributed intrinsic property of the HCG molecules. It is also concluded that the gonadotrophic activity of biologically pure HCG in immature hypophysectomised female rats consists of a specific stimulation of the interstitial cell apparatus. Such HCG preparations do not induce any follicle stimulation, not even when administered in excessive doses.

MECHANISM OF THE SELECTIVE SURGE OF FOLLICLE-STIMULATING HORMONE IN DIOESTROUS RATS DURING THE INDUCTION OF OVULATION BY HUMAN CHORIONIC GONADOTROPHIN

1980 ◽  
Vol 86 (3) ◽  
pp. 489-495 ◽  
Author(s):  
SHUJI SASAMOTO ◽  
KAZUYOSHI TAYA
Keyword(s):  
Luteinizing Hormone ◽  
Follicle Stimulating Hormone ◽  
Time Of Day ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Normal Cycle ◽  
Luteinizing Hormone Releasing Hormone ◽  
Immature Rats ◽  
Lh Release ◽  
Lh Rh

A selective surge of FSH with a small concomitant rise in LH occurred invariably in rats when ovulation was induced by injecting human chorionic gonadotrophin (HCG) at various reproductive stages such as day 15 of lactation and in 29-day-old immature rats as well as in dioestrous animals. No FSH surge occurred on day 3 of lactation or in 26-day-old immature rats in which ovulation could not be induced by HCG. The FSH surge occurred 6–18 h after HCG treatment regardless of the time of day of injection of HCG. Ovulation began by 12 h and was completed by 18 h after injection of HCG. Pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) with respect to FSH release strikingly increased at 01.00 h on day 1 after HCG injection at 17.00 h of dioestrus (day 0) to levels similar to those of the group at 01.00 h of oestrus, when the greatest response was noted during the normal cycle. With regard to LH release pituitary responsiveness to LH-RH at 01·00 h on day 1 markedly increased but the response was only about half of the response at 01·00 h of oestrus and one third of the response at 17.00 h of pro-oestrus when the greatest response was noted during the normal oestrous cycle. These results indicate that during ovulation the pituitary gland of the rat is highly responsive to LH-RH with respect to the release of FSH, for which secretory changes in the ovary after an ovulating dose of HCG may be responsible.

A PROGESTERONE-DEPENDENT STEP IN OVULATION INDUCED BY HUMAN CHORIONIC GONADOTROPHIN IN IMMATURE RATS PRIMED WITH PREGNANT MARE SERUM GONADOTROPHIN

1980 ◽  
Vol 87 (1) ◽  
pp. 105-107 ◽  
Author(s):  
HEIGO KOHDA ◽  
TAKAHIDE MORI ◽  
YOJIRO EZAKI ◽  
TOSHIO NISHIMURA ◽  
AKIRA KAMBEGAWA
Keyword(s):  
Experimental System ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Immature Rats ◽  
Ovulatory Process ◽  
Pregnant Mare Serum Gonadotrophin

In immature rats primed with pregnant mare serum gonadotrophin, antiserum to progesterone could prevent or reduce ovulation in response to injected human chorionic gonadotrophin (HCG). To be effective, antiserum treatment had to be within 6 h of gonadotrophin treatment; antiserum given 9 h after HCG was ineffective. Progesterone restored the antiserum blocked ovulation completely or incompletely when administered intravenously within 6 h of treatment with HCG. The first 6 h was shown to be a progesterone-dependent step in the ovulatory process in this experimental system.

Co-operation of progesterone and prostaglandins in ovulation induced by human chorionic gonadotrophin in immature rats primed with pregnant mare serum gonadotrophin

1983 ◽  
Vol 96 (3) ◽  
pp. 387-393 ◽  
Author(s):  
Heigo Kohda ◽  
Takahide Mori ◽  
Toshio Nishimura ◽  
Akira Kambegawa
Keyword(s):  
Inhibitory Action ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Temporary Increase ◽  
Inhibitory Effects ◽  
Concurrent Administration ◽  
Simultaneous Injection ◽  
Induced Ovulation ◽  
Immature Rats ◽  
Pregnant Mare Serum Gonadotrophin

Serial injections of a mixture of prostaglandin (PG) E2 and F2α 0, 2, 4, and 6 h after simultaneous injection of human chorionic gonadotrophin (hCG) and indomethacin incompletely restored the ovulation that would have been blocked by indomethacin in immature rats treated with pregnant mare serum gonadotrophin followed by hCG. Serial injections of another mixture of PGE2 and PGF2α 6, 8, 10 and 12 h after simultaneous injection of hCG and indomethacin similarly reversed, in part, the inhibitory effects of indomethacin on hCG-induced ovulation. In contrast, serial injections of the mixtures of PGE2 and PGF2α 0, 2, 4, 6, 8, 10 and 12 h after simultaneous injection of hCG and indomethacin completely restored the indomethacin-blocked ovulation, suggesting that the prostaglandins mediate the action of hCG on ovulation both in the earlier and later stages of the preovulatory process. Six hours after simultaneous injection of hCG and indomethacin serial injections of a mixture of PGE2 and PGF2α reproduced the acute and temporary increase in concentrations of progesterone and testosterone in plasma which would have been abolished by indomethacin. Progesterone given concurrently with hCG and indomethacin partially antagonized the inhibitory action of indomethacin on ovulation. Serial injections of a' mixture of PGE2 and PGF2α 6, 8, 10 and 12 h after concurrent administration of progesterone with hCG and indomethacin completely restored the indomethacin-blocked ovulation, suggesting that progesterone can substitute the action of prostaglandins injected serially in the first half of the preovulatory process. It was concluded that the co-operation of progesterone in the earlier stage and of prostaglandins in the later stage of the preovulatory interval is required to mediate the action of hCG on ovulation.

CHANGES IN STEROID CONCENTRATION IN THE OVARIES OF IMMATURE RATS TREATED WITH PREGNANT MARE SERUM GONADOTROPHIN AND HUMAN CHORIONIC GONADOTROPHIN

1977 ◽  
Vol 75 (1) ◽  
pp. 43-48 ◽  
Author(s):  
S. BAUMINGER ◽  
B. ECKSTEIN ◽  
H. R. LINDNER
Keyword(s):  
Dehydrogenase Activity ◽  
Hydroxysteroid Dehydrogenase ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Immature Rat ◽  
Immature Rats ◽  
Rat Ovary ◽  
Pregnant Mare Serum Gonadotrophin

The concentrations of testosterone, progesterone and 20α-hydroxypregn-4-en-3-one (20α-OHP) were measured in the ovaries of immature rats in which ovulation was induced by treatment with pregnant mare serum gonadotrophin (PMSG) and, 48 h later, with human chorionic gonadotrophin (HCG). The concentration of testosterone in the tissue increased significantly 48 h after treatment with PMSG, reached a peak 4 h after the administration of HCG and declined to the basal level 4 h later. Increases in the levels of progesterone and 20α-OHP were observed 4 h after the administration of HCG. Whereas the level of 20α-OHP continued to rise during the subsequent 30 h, progesterone levels declined near the presumed time of ovulation (12 h after administration of HCG). It is concluded that 20α-hydroxysteroid dehydrogenase activity is present in the immature rat ovary before ovulation and that an increase in the production of testosterone in the ovaries of rats treated with PMSG and HCG precedes increased production of progesterone and 20α-OHP in these ovaries.

Sign in / Sign up

Export Citation Format

Share Document